Pacific University is part of a new multi-center research study examining a new treatment hoped to slow the progression of myopia, or nearsightedness.

The CHAMP (Childhood Atropine for Myopia Progression) Study is a multi-center FDA drug trial that studies the long-term safety and efficacy of low-dose atropine eye drops on myopia progression control. The study will be conducted at the College of Optometry on Pacific's Forest Grove Campus.

Myopia, or nearsightedness, is caused when the eye grows too long, so light doesn't focus accurately on the retina. It often increases during school years as the eye continues to grow.

Children ages 3 to 10 who have been diagnosed with myopia in both eyes may be eligible to participate in the study. Participants will receive all study-related visits, eye exams and eye drops at no cost, along with a yearly allowance for glasses and/or contact lenses. Participation will continue for four years.

Learn more by calling CHAMP Study Hotline 503-352-3147 or email 



When sliding the bar to the right, the above simulation shows what a person with myopia may see with uncorrected vision. Myopia, or nearsightedness, means distance vision is blurry.


Research Team Lead

Chunming Liu, OD, PhDThe research team of CHAMP study at Pacific is led by associate professor of optometry, Chunming Liu, OD PhD.

Education | Dr. Liu is a graduate of Washington State University where she earned her PhD in neuroscience. She received her OD degree from New England College of Optometry.

Specialty | Dr. Liu’s primary clinical and research interests are focused on pediatric optometry and visual development. She has extensive experience in providing high quality care in these areas. She aims to promote better understanding of the basic neuronal mechanisms of visual function development, to explore the pathophysiology and to develop effective treatment strategies for visual dysfunction.



Participants will receive all study-related visits, eye exams, eye drops and more for free.

Smiling children outdoors

While myopia is a common and treatable condition, researchers are concerned about how many more people are nearsighted today than in relatively recent years.

Young girl watching device and rubbing eye

Any parent who learns about the growth of myopia cases, and of their possible effects, has a simple, urgent question: How can I tell if my child has myopia?